Ashurst, United Kingdom

Jeremy David Hinks


Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Horsham, GB (1997 - 2001)
  • Ashurst, GB (2006)

Company Filing History:


Years Active: 1997-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Jeremy David Hinks: A Glimpse into His Patented Discoveries

Introduction

Jeremy David Hinks is an innovative inventor based in Ashurst, Great Britain, recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of four patents, his work primarily focuses on the development of novel compounds with antibacterial properties, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest contributions to the field, Hinks has developed several key compounds. One notable patent features a class of compounds known as 2-(pyrazol-3-yl)carbapenem derivatives. These compounds exhibit a formula where R can be hydrogen or various substituted groups, indicating a versatile range of potential applications. This invention highlights not only the synthesis of these compounds but also their pharmaceutical compositions, suggesting broad-spectrum antibacterial activity and stability.

Another significant patent details carbamoyloxy derivatives of mutiline, emphasizing their efficacy in treating bacterial infections. The patented derivatives, wherein R can be ethyl or vinyl, are distinguished by their carbamoyloxy group characteristics. Such innovations underline Hinks's contribution to tackling bacterial resistance in medicine.

Career Highlights

Hinks's inventive journey is supported by his position at SmithKline Beecham Corporation, a company known for its dedication to healthcare innovations. His role within this esteemed organization allows him to continue his research and develop groundbreaking solutions aimed at improving patient outcomes through advanced pharmaceuticals.

Collaborations

Throughout his career, Hinks has collaborated with notable professionals, including Eric Hunt and Steven Coulton. These partnerships exemplify the importance of teamwork in scientific discovery, leading to enhanced innovations and the successful development of new therapeutic agents.

Conclusion

Jeremy David Hinks continues to make a significant impact in the field of pharmaceuticals with his inventive spirit and dedication to research. With his impressive portfolio of patents, he remains an important figure in the ongoing battle against bacterial infections, contributing to the advancement of healthcare solutions. His work, supported by collaborations and his role at SmithKline Beecham Corporation, highlights the innovative pathways he is charting in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…